Inventor · Duarte, CA, US

John C. Williams

29Patents
6h-index
24Co-inventors
69Inventor score

Filing activity: Oct 28, 1976 → Jul 3, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US4076380A Graded index optical fiber Physics 39 Expired
US9574014B2 Chimeric antigen receptor compositions Chemistry; Metallurgy 35 Active
US8962804B2 Meditopes and meditope-binding antibodies and uses thereof Chemistry; Metallurgy 33 Active
US8895702B2 Development of masked therapeutic antibodies to limit off-target effects; application to anti-EGFR antibodies Chemistry; Metallurgy 19 Active
US10357571B2 Development of masked therapeutic antibodies to limit off-target effects Chemistry; Metallurgy 13 Active
US6881008B1 Particle binding compositions and methods of making and using such compositions Fixed Constructions 7 Expired
US8658774B2 Meditopes and related meditope-monoclonal antibody delivery systems, synthesis and therapeutic uses thereof Emerging Cross-Sectional Technologies 6 Active
US9669108B2 Meditopes and meditope-binding antibodies and uses thereof Chemistry; Metallurgy 6 Active
US11116834B2 Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy Chemistry; Metallurgy 5 Active
US9193791B2 Development of masked therapeutic antibodies to limit off-target effects Chemistry; Metallurgy 4 Active
US7021864B2 Soil binding and revegetation compositions and methods of making and using such compositions Fixed Constructions 3 Expired
US9428553B2 Meditopes and meditope-binding antibodies and uses thereof Chemistry; Metallurgy 3 Active
US10590205B2 Chimeric antigen receptor compositions Chemistry; Metallurgy 2 Active
US10414814B2 Tumor-selective CTLA-4 antagonists Chemistry; Metallurgy 2 Active
US10689423B2 CTLA4-binding protein peptide-linker masks Chemistry; Metallurgy 1 Active
US11690908B2 Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy Chemistry; Metallurgy 1 Active
US9096844B2 Photocleavable linker Physics 1 Active
US11926652B2 CTLA4-binding protein peptide-linker masks Chemistry; Metallurgy 0 Active
US12384845B2 Activatable masked anti-CTLA4 binding proteins Chemistry; Metallurgy 0 Active
US11311622B2 Development of masked therapeutic antibodies to limit off-target effects Chemistry; Metallurgy 0 Active
US11279752B2 Tumor-selective CTLA-4 antagonists Chemistry; Metallurgy 0 Active
US12358998B2 Anti-CD6 antibody-growth factor complex for treating autoimmune diseases Chemistry; Metallurgy 0 Active
US12161714B2 Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy Chemistry; Metallurgy 0 Active
US12060435B2 Multi-specific ligand binders Chemistry; Metallurgy 0 Active
US11246942B2 Meditopes and meditope-binding antibodies and uses thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.